Titel

Merkliste
1 Ergebnisse

Overall survival indirect treatment comparison between brig..:

Reckamp, KL ; Lin, HM ; Cranmer, H...
Current Medical Research and Opinion, 2022, 38 (9), pp. 1587 - 1593. , 2022

Link: https://repository.icr.ac.uk/handle/internal/5521

RT Journal
T1 <Title>Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase-positive non-small cell lung cancer using data from ALEX and final results from ALTA-1L</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftinstcancerres:oai:repository.icr.ac.uk:internal_5521&Exemplar=1&LAN=DE
				
A1 Reckamp, KL
A1 Lin, HM
A1 Cranmer, H
A1 Wu, Y
A1 Zhang, P
A1 Kay, S
A1 Walton, LJ
A1 Shen, J
A1 Popat, S
A1 Camidge, DR
PB TAYLOR & FRANCIS LTD
YR 2022
K1 ALK+ NSCLC
K1 alectinib
K1 brigatinib
K1 indirect treatment comparison
K1 overall survival
K1 Anaplastic Lymphoma Kinase
K1 Carbazoles
K1 Carcinoma
K1 Non-Small-Cell Lung
K1 Crizotinib
K1 Humans
K1 Lung Neoplasms
K1 Organophosphorus Compounds
K1 Piperidines
K1 Protein Kinase Inhibitors
K1 Pyrimidines
JF Current Medical Research and Opinion, 2022, 38 (9), pp. 1587 - 1593
LK http://dx.doi.org/https://repository.icr.ac.uk/handle/internal/5521
DO https://repository.icr.ac.uk/handle/internal/5521
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)